New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 9, 2012
12:35 EDTMMM, DGXQuest Diagnostics unit, 3M say FDA gives clearance for Simplexa test
Focus Diagnostics, a business of Quest Diagnostics (DGX), and 3M (MMM) announced that the U.S. Food and Drug Administration has provided 510(k) clearance and CLIA moderate-complexity categorization to the Simplexa Flu A/B & RSV Direct test on the 3M Integrated Cycler. The new test aids in the qualitative detection and differentiation of RNA of influenza A and B viruses and respiratory syncytial virus, common causes of respiratory illness. The Simplexa Flu A/B & RSV Direct is now available in the United States. It was CE marked for distribution in Europe in 2011.
News For DGX;MMM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2015
16:31 EDTMMMOn The Fly: Closing Wrap
Subscribe for More Information
12:28 EDTMMMOn The Fly: Midday Wrap
Subscribe for More Information
09:43 EDTMMM3M Company sees Swiss franc immaterial to 2015 results
Subscribe for More Information
09:33 EDTMMM3M sees forex hurting EPS by about 20c y/y in 2015
Subscribe for More Information
09:25 EDTMMM3M Company says sees continued momentum in 2015
Subscribe for More Information
08:53 EDTMMM3M Company sees FY15 gross share repurchases $3B-$5B
Sees FY15 CapEx $1.5B-$1.7B. Sees further foreign currency headwinds being offset by lower than expected input costs in FY15. Says foreign currency translation expected to be a headwind of -4% to -5% in FY15. Sees FY tax rate 28%-29%. Comments from slides that will be presented on the Q4 earnings conference call.
07:32 EDTMMM3M Company sees FY15 EPS $8.00-$8.30, consensus $8.20
Subscribe for More Information
07:31 EDTMMM3M Company affirms FY15 performance expectations
Subscribe for More Information
07:31 EDTMMM3M Company reports Q4 EPS $1.81, consensus $1.80
Reports Q4 revenue $7.7B, consensus $7.77B. Organic local-currency sales grew 6.3 percent with acquisitions adding 0.1 percent to sales. Foreign currency translation reduced sales by 4.4 percent year-on-year.
January 26, 2015
15:40 EDTMMMNotable companies reporting before tomorrow's open
Subscribe for More Information
15:23 EDTMMM3M Company technical comments before results
The shares have a potential bearish head and shoulders top in development. The neckline for the pattern remains at considerable distance from current price at the $155 area. It would take more bearish news than current expectations would suggest to reach the neckline. Downside potential for the pattern, if it triggers, would be to the $142 area over time. It should be noted that on a long-term chart the price action of recent years has resulted in a near-vertical rise that appears unsustainable. If the news is more bullish than expected, resistance levels to watch as potential upside objectives would be at $165.99 and then at $168.16, the 52-week high and lifetime high. On a breakout above $168.16, a run to $170 to $175 may be possible.
January 22, 2015
10:03 EDTMMMOn the Fly: Analyst Initiation Summary
Subscribe for More Information
January 21, 2015
16:14 EDTMMM3M Company initiated with a Buy at UBS
Target $195.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use